Editorial: Advances in the treatment of primary central nervous system lymphoma
(Source: Frontiers in Oncology)
Source: Frontiers in Oncology - August 14, 2023 Category: Cancer & Oncology Source Type: research
Intracranial hematolymphoid malignancies: A case series with molecular characterization
CONCLUSIONS: Our case series provides insight into unique pathological phenotypes of hematologic neoplasms with atypical CNS involvement. We offer targets for future studies by identifying potentially pathogenic genetic variants in these lesions, as the full implications of the novel molecular abnormalities described remain unclear.PMID:37573681 | DOI:10.1016/j.clineuro.2023.107928 (Source: Clinical Lymphoma and Myeloma)
Source: Clinical Lymphoma and Myeloma - August 13, 2023 Category: Cancer & Oncology Authors: Rebekah G Langston Heather Pinckard-Dover Grace Guzman Christopher P Wardell Murat Gokden T W Morris J D Day Analiz Rodriguez Source Type: research
Intracranial hematolymphoid malignancies: A case series with molecular characterization
CONCLUSIONS: Our case series provides insight into unique pathological phenotypes of hematologic neoplasms with atypical CNS involvement. We offer targets for future studies by identifying potentially pathogenic genetic variants in these lesions, as the full implications of the novel molecular abnormalities described remain unclear.PMID:37573681 | DOI:10.1016/j.clineuro.2023.107928 (Source: Clinical Lymphoma and Myeloma)
Source: Clinical Lymphoma and Myeloma - August 13, 2023 Category: Cancer & Oncology Authors: Rebekah G Langston Heather Pinckard-Dover Grace Guzman Christopher P Wardell Murat Gokden T W Morris J D Day Analiz Rodriguez Source Type: research
First-line induction chemotherapy with high-dose methotrexate versus teniposide in patients with newly diagnosed primary central nervous system lymphoma: a retrospective, multicenter cohort study
This study aimed to compare the efficacy and safety of high-dose methotrexate (HD-MTX) versus teniposide (TEN) in patients with newly diagnosed immunocompetent primary central nervous system lymphomas (PCNSLs). (Source: BMC Cancer)
Source: BMC Cancer - August 11, 2023 Category: Cancer & Oncology Authors: Kaili Zhong, Yanyan Shi, Yuhuan Gao, Huilai Zhang, Mingzhi Zhang, Qiaohua Zhang, Xinan Cen, Mei Xue, Yan Qin, Yu Zhao, Liling Zhang, Rong Liang, Ningju Wang, Yan Xie, Yu Yang, Aichun Liu & hellip; Tags: Research Source Type: research
Central nervous system metastasis in a young female patient with primary mediastinal large B-cell lymphoma: A case report and literature review
CONCLUSION: Till date, only a few cases of central nervous system (CNS) metastasis have been reported in the literature. Moreover, CNS metastasis of refractory PMBCL is an uncommon event with a poor prognosis. Brain metastases are often the ultimate fatal consequence of many aggressive cancers, so early detection and treatment are important.PMID:37560590 | PMC:PMC10408608 | DOI:10.25259/SNI_414_2023 (Source: Surgical Neurology International)
Source: Surgical Neurology International - August 10, 2023 Category: Neurosurgery Authors: Khalid Talal Alghamdi Ghaida Abdullah Albattah Shoug Saleh Alnasyan Ali Zaki Alhabib Alaa Mohammed Noor Samkari Hussam Yousef Kutub Source Type: research
